不差异化的形肉瘤与心脏引起的不匹配修复缺陷
Callum E Yates1, Gerard W Connors1, Anjan Gurung1
1Princess Alexandra Hospital, Brisbane, Australia.
JACC. Case reports
|June 6, 2025
概括
遗传性癌症综合征很少导致心脏瘤. 这项案例研究揭示了一种具有特定遗传标记的原发性心脏瘤,这表明与林奇综合征有联系.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 心脏病学 心脏病学
背景情况:
- 心脏恶性瘤很少与遗传性癌症倾向有关.
- 家庭癌症综合征,如林奇综合征,通常与胃肠道和妇科癌症有关.
研究的目的:
- 报告一种罕见的初级心脏瘤病例.
- 调查心脏瘤与遗传癌症综合征,特别是林奇综合征之间的潜在关联.
主要方法:
- 对初级心脏瘤的组织病理学检查.
- 针对不匹配修复 (MMR) 基因表达的免疫组织化学分析.
主要成果:
- 心脏瘤表现出对不匹配修复基因的染色损失.
- 这种分子现象型是林奇综合征的特征.
结论:
- 初级心脏瘤可以呈现出通常在林奇综合征中见到的遗传改变.
- 这一发现扩大了已知的林奇综合征相关表型的范围,并表明了心脏恶性瘤和家族性癌症综合征之间的潜在,尽管很少见的联系.
更多相关视频
07:18Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
Published on: June 13, 2019
7.1K
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
2.1K
相关概念视频
Mismatch Repair
5.2K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
5.2K
Cardiomyopathy I: Introduction and Classification
72
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
72
Cardiomyopathy III: Hypertrophic Cardiomyopathy
67
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
67
Satellite Stem Cells and Muscular Dystrophy
2.1K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.1K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Cancers Originate from Somatic Mutations in a Single Cell
13.1K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.1K
